HRSA Releases Results of Pharmacist Manpower Study

N A T I O N A L A S S O C I A T I O N O F B O A R D S O F P H A R M A C Y

A I D T O G O V E R N M E N T – T H E P R O F E S S I O N – T H E P U B L I C – 1 9 0 4 T O 2 0 0 1 HRSA Releases Results of Pharmacist Manpower Study

In December 1999, the US NABP contributed to the verification issues; and a Congress asked the Secretary of development of this report by change in the composition of the Department of Health and furnishing the HRSA study the pharmacy workforce (ie, an Human Services (HHS) to group with pharmacist demo- increase in the number of determine whether and to what graphic information as sup- women and the advent of other extent there was a pharmacy plied by the state boards of professional opportunities manpower shortage. One year pharmacy for the Survey of outside of the pharmacy). Wild later in December 2000, the Pharmacy Law and the reports cards that may affect the Health Resources and Services of the Task Force on Pharmacy projected demand include Administration (HRSA) of the Manpower Shortage and the increased reliance on automa- HHS released The Pharmacist Committee on Law Enforce- tion and technicians in the Workforce: A Study of the Supply ment/Legislation, as they dispensing process and unfore- and Demand for Pharmacists, pertained to the roles of seen changes in the market. which details the factors technicians and regulating for The report suggests that the leading to the shortage of pharmaceutical care outcomes. shortage of pharmacists may

pharmacists and its impact on The HRSA report is composed have a very real impact on the practice of pharmacy and of five chapters entitled: The pharmacies and the public, the public health. Pharmacist Shortage; Factors resulting in reduced time for HRSA confirms that a real Influencing the Demand for (continued on page 38) shortage of pharmacists exists Pharmacists and Pharmaceuti- and notes, “This shortage is cal Care Services; Expanding considered a dynamic shortage Professional Roles, Quality of since it appears to be due to a Pharmaceutical Care, and rapid increase in the demand Prevention of Medication New Online 39Pharmacy Models for pharmacists coupled with a Errors; The Supply of Pharma- Expand Practice Landscape constrained ability to increase cists and Pharmacy Education the supply of pharmacists. The and Training; and Summary of factors causing the current Comments from Public and Optional Events, 46Spouse/Guest Program shortage are of a nature not Private Sectors. th likely to abate in the near Enhance 97 Annual Meeting future without fundamental The Pharmacist Shortage changes in pharmacy practice The HRSA points to several and education.” factors contributing to the NABP’s50 Examination shortage, including an in- The report corroborates anec- Committee Members dotal accounts of unfilled creased use of prescription pharmacist positions from medications; market factors, employers in all practice settings including market growth and and all regions of the country. competition and third-party Mississippi52 Board Pursues Diversion Problem

ON OF B TI OA IA R C D O S S S O A F

L H

C V O L U M E 3 0 - N U M B E R 3 - M A R C H 2 0 0 1 N

Y in this issue

1904 ® HRSA Releases Results of Pharmacist Manpower Study (continued from page 37) patient counseling; job stress Expanding Professional n New drugs are appearing on leading to a potential for Roles, Quality of the market at a faster rate, increased medication errors; Pharmaceutical Care, requiring the continuous restricted service to and Error Prevention updating of a pharmacist’s underserved populations; and information base and the recruitment of pharmacy The HRSA report recognizes counseling skills; and and validates the need for the practice faculty away from the n The increase in drug diver- expanded range of services colleges of pharmacy, which sity and complexity have offered by practicing pharma- could lead to a restriction in contributed to a greater cists in the 21st century. Key class size. number of medication errors findings relevant to these in the United States. Factors Influencing the issues include the following: The report points out that Demand for Pharmacists n Quality care as it pertains studies have shown that Between 1990 and 1999, the to pharmacists is ex- pharmacists can contribute to number of prescriptions tremely relevant at this reducing the cost of health care dispensed in retail settings time, in light of the while at the same time improv- increased by 44% from 1.9 existing shortage. The ing patients’ use of medi- billion to 2.8 billion. The report 1999 Institute of Medicine cations and health outcomes attributes this increase to the report, To Err is Human: and that pharmacists play a usual suspects: a growing and Building a Safer Health key role in preventing medica- aging population, increased System emphasized the tion errors. third-party coverage (the report importance of human takes into consideration the factors in decreasing the (continued on page 48) proposed Medicare prescription number of medication drug benefit and projects that errors: maintaining

ON OF B reasonable working hours, TI OA IA R about 78% of US prescription C D O S S S O volume is covered by third workloads and staffing A F P

L H

ratios, and avoiding I

parties), direct-to-consumer T

C N marketing, and the introduc- distractions; Y 1904 ® tion of new and better drugs. n The expanding role of The use of prescription medica- pharmacists increases as The NABP Newsletter (ISSN 0027-5700) is published ten times tion has increased as more medications become more a year by the National Association of Boards of Pharmacy (NABP) to educate, diseases and medical condi- complex and diverse, which to inform, and to communicate the tions become treatable by objectives and programs of the may lead to more drug Association and its 68 member boards of medications. According to the misuse. In addition to pharmacy to the profession and the public. The opinions and views HRSA report, spending on patient counseling, the role expressed in this publication do not necessarily reflect the official views, prescription drugs increased of today’s pharmacist opinions, or policies of NABP or any from 5.6% of total health care board unless expressly so stated. The includes drug monitoring subscription rate is $35 per year. spending in 1993 to 8.5% in and disease management National Association of Boards of Pharmacy 2000 and is expected to in- for defined conditions; 700 Busse Highway Park Ridge, Illinois 60068 crease to 10.3% by 2005. The patient education; and 847/698-6227 report specifically points out www.nabp.net furthering public health [email protected] that the projected growth of the initiatives such as smoking Carmen A. Catizone prescription drug market will cessation programs, Executive Director/Secretary continue to outstrip the diabetes education, and Courtney M. Karzen Editorial Manager number of practicing pharma- immunizations; © 2001 National Association of Boards of cists in the future. Pharmacy. All rights reserved. No part of this publication may be reproduced in any manner without the written permission of the Executive Director/Secretary of the National Association of Boards of Pharmacy.

M A R C H 2 0 0 1 38 New Online Pharmacy Models Expand Practice Landscape

Behind the clicks and excite- Merck-Medco Managed Care, that offers personal care and ment of online shopping, the LLC, both of which promote prescription sales, cut its staff world of Internet pharmacy is pharmacy benefits management 15% in June 2000. In February complex and may assume (PBM) services. PBMs contract 2001, it announced that it was various models of operation. with employers to provide giving up its retail sales Most online operations volume discounts for employees’ effective March 12, and pur- utilize one of four basic medications. According to chasing an existing specialty service models that reflect the insure.com, an online insurance prescription pharmacy, which evolving nature of these new and research company, PBMs it has yet to name. Planet- pharmacy practice sites. coordinate the transaction Rx.com is referring its patients

The “brick-and-mortar” model between the drug company, the to former rival drugstore.com is most often used by online insurer, and the pharmacies and for retail services. Michael pharmacies that are typically administer about 85% of the Beindorff, chairman and chief an adjunct to existing pharma- prescription medication used by executive officer of Planet- cies with a storefront presence. the nation’s insured. Rx.com, said, “Industry ana- lysts estimate the specialty Examples of this model are The online-only model has no pharmacy segment to have CVS.com, Eckerd.com, storefront presence. These approximately $14 billion in Familymeds.com, and Wal- entities were the first to annual sales nationwide and a greens.com. CVS’s purchase of become involved in online growth rate higher than the Soma.com added an Internet pharmacy practice. According overall pharmacy market. With presence to its 4,200 stores to insure.com, businesses in this agreement we are repur- east of the Mississippi. this third category have posing the extensive health Familymeds.com relied on the difficulty signing contracts care expertise, relationships, name recognition of its well- with PBMs, which earn brand, and other assets of established chain stores in the revenue through mail orders. PlanetRx against a faster northeastern part of the country Moreover, unlike the brick- growing, less costly, higher to build an online mail-order and-mortar online model, margin business opportunity.” sales division to attract patients there are no physical facili- nationwide. Name recognition is ties at which patients may The fourth online pharmacy a benefit for these established model is also the newest and pick up their prescriptions. pharmacies, and many brick- fastest growing. The network To remedy this situation, and-mortar operations offer model is composed of indepen- prescription pickup services for drugstore.com, one of the first dent pharmacies that partner their online customers, which online-only pharmacies, with an Internet company to maintain face-to-face counsel- partnered with the Rite Aid gain online marketing expertise ing and interaction between the chain to build a supply and and attract new patients. Most pharmacist and patient. mail-order facility in New independents offer the conve- Jersey. Another online-only The second model is that of the nience of same-day delivery. company, Rx.com, has taken a exclusively mail-order com- The online companies generate different approach: it operates pany. These Internet sites their revenue by either charging its own fleet of vehicles in appeared early on as a way to affiliates set fees or by claiming major markets to provide same- offer greater convenience to commissions from actual sales. day delivery. contract partners and other A modification of this model service entities, rather than to The winds of change are being charges no maintenance fees attract individual customers. felt by the new online-only and relies on the sales Larger businesses of this type businesses. PlanetRx.com, a themselves to generate include Caremark, Inc, and founding entity of the Internet (continued on page 44)

M A R C H 2 0 0 1 39 LegalBriefs Shred Lightly and Carry a Disciplinary Stick By Dale J. Atkinson, JD antibiotic usage, open prescrip- management of chronic pain The procedures for tions and instructions for patients. The physician was investigating, tranquilizers, and the avail- also directed to maintain prosecuting, and ability of call coverage. thorough and written treat- adjudicating a This investigative information ment plans for all patients and licensee can be led to a disciplinary hearing to cease and desist from complex, and such held by a three-member panel telephone refills for prescrip- complexities may of the board composed of two tions of controlled substances. provide attorneys practitioners and one public The physician appealed the for licensees with member. Substantial documen- matter to the district court the ability to contest board tary evidence in the form of which affirmed the ruling of actions. Boards of pharmacy pharmacy records along with the board in its entirety. must be aware of these intri- testimony of several individuals Thereafter, the physician cate procedures and have some led to a recommendation of appealed the matter to the working knowledge of the discipline to the board by the Iowa supreme court for review. process by which information panel. A summary of the On appeal, the physician is gathered and eventually deficiencies or substandard argued three principal issues: presented in an administrative care by the physician included: 1) The composition of the disciplinary hearing. Board inadequately evaluating disciplinary panel, which practices should be carefully patients on an individual basis included only two scrutinized by the representa- before prescribing medications, licensed professionals, tive counsel to determine prescribing antibiotics for violated the equal compliance with state and/or prolonged periods of time, and protection clauses of the federal constitutions or stat- prescribing narcotic and Iowa and United States utes. Consider the following anxiolytic medications to Constitutions; fact pattern. patients with non-terminal 2) The board policy of Stemming from a call from a chronic pain without ad- destroying original licensed pharmacist, the equately pursuing and docu- investigative materials pharmacy board investigator menting use of available upon filing the com- scrutinized the prescription alternatives. Furthermore, the plaint violates applicable practices of a physician. Based physician was found to have Iowa law; upon the information gathered prescribed inappropriately large during the preliminary investi- amounts of narcotics for 3) The Doctrine of Laches, gative process, charges were inappropriately long periods of as well as the lack of initiated by the state board of time to patients who were patient complaints, medical examiners, alleging diagnosed with substance deprives the board of substandard treatment of abuse or dependence. jurisdiction. patients. Under applicable Based upon the recommenda- The state supreme court statutes, a “peer review panel” tions of the panel, the board addressed the issues in order, was convened to examine the placed the physician on beginning first with the compo- medical records of 12 of the probation for two years subject sition of the disciplinary panel. physician’s patients. After to the condition that he secure Citing previous cases, the review, the panel expressed 60 hours of continuing educa- supreme court held that, due concerns regarding the tion, including course work in to the lower evidentiary stan- amounts and frequency of recordkeeping as well as in dard applicable to physician scheduled drug prescriptions,

M A R C H 2 0 0 1 40 disciplinary actions (as op- the investigative report submit- available to fully comprehend posed to the higher criminal ted to the board and made the circumstances in dispute. standard), the state was free to available for examination by While recognizing that a laches deal with different professions the licensee. In its analysis, defense clearly applies in a differently without violating the supreme court held that professional disciplinary action the equal protection guaran- the deliberate destruction of in Iowa, the court held it must tees established under the the investigative files casts be proven that the delay was applicable constitutions. doubt on the integrity of the unreasonable and that preju- Because the rationale of entire disciplinary process. By dice to the licensee had oc- providing sub-panels of the its conduct, the court contin- curred. Under the current board to initially hear matters ued, the board had necessarily circumstances, the court held reflected the legislative intent shifted the inquiry from what that given the number of to increase participation by the board provided to the patients, the extent of medical public members on the medical licensee to speculation about and pharmacy records and the board as well as reduce the what it withheld. variety of quality of care issues time frames that expire during Based upon an analysis of the involved, the length of time the disciplinary process justify statute, the court held that the between the initial investiga- the use of the sub-panel. board’s policy of destroying tions and the ultimate pros- Therefore, the court found that field files upon the filing of a ecution was not unreasonable. the statute easily meets the formal complaint violated Finally, the court was constitutional protections of applicable Iowa law. However, unconvinced by the physician’s the equal protection clause. the court also held that the argument that because no Addressing the destruction of failure to comply with the complaints were filed by the investigative file, the applicable statute did not patients, the board could not supreme court was challenged entitle the licensee, under render disciplinary action. by this unique procedure these circumstances, to relief. Applicable Iowa law specifically undertaken by the board. The In other words, the licensee authorized the licensing board investigator for the medical had failed to prove that his to review and investigate board revealed a board policy substantive rights had been alleged acts or omissions that called for the destruction prejudiced by the board action. involving substandard care, of the investigator’s “field files” Accordingly, the court held whether “upon written com- immediately upon the filing of that while the board policy plaint or upon its own motion a formal complaint against a violated applicable law, in this pursuant to evidence received.” licensee. That is, handwritten case, such application did not As stated by the supreme court, notes or memoranda relied prejudice the licensee. “actual injury to a patient need upon by the investigator in the Finally, the court addressed not be established.” The court preparation of a report, but not the issue of whether the also noted that patients who included as an attachment, Doctrine of Laches and the receive large quantities of were destroyed. Consequently, failure of patient complaints controlled substances for pain these materials were not divested the board of jurisdic- are not likely to file complaints available for examination by tion to discipline the licensee. with a regulatory board. the licensee through the A laches defense rests on the Based upon the foregoing, the discovery process. claim that sufficient time has court upheld the actions of the In support of its policy, the passed to prejudice a licensee board in disciplining the board argued that all pertinent so that evidence may not be (continued on page 52) evidence is incorporated into

M A R C H 2 0 0 1 41 The AcademicPerspective The Challenges of Pharmacogenomics for Pharmacy Regulation By David B. Brushwood, JD are due to genetic differences. metabolizer can enable physi- Under the law, The hope is that a simple cians and pharmacists to pharmaceutical genetic test can predict how a predict how a patient will products have patient will respond to a drug respond to beta blockers, traditionally been before it is taken. antidepressants, considered “un- Consider, for example, the drug antipsychotics, codeine, and avoidably unsafe” 6-mercaptopurine, one of the tamoxifen, as well as to several products. Pharma- mainstays of treatment for other drugs. A genetic test will ceuticals, even acute lymphoblastic leukemia, soon be available to test for when prescribed a common type of childhood variations in the gene for 2d6. appropriately, may produce cancer. Researchers have It is possible that some pa- injury or fail to relieve human recently reported that the tients, for whom codeine has suffering. Such therapeutic reason some patients are been ineffective as an analge- failures and toxicities have harmed by the drug is that they sic, may have been inaccurately generally been considered have an unusually low level of labeled as “drug abusers” or regrettable and tragic, but they thiopurine methyltransferase “drug seekers” due to their also have been viewed as (TPMT), an enzyme that helps requests for higher doses of the unpreventable and legally have the body metabolize and drug. These patients may now been deemed the fault of no eliminate the drug. A blood test be identified as having an one. They are the unfortunate has been developed to facilitate inactive form of the 2d6 gene costs of scientific uncertainty adjustments in dose, but a and therefore be unable to and the mysteries of human quicker and more efficient DNA metabolize codeine into its physiology. Because these test that identifies the gene for desired metabolite, morphine. unintended effects have been producing TPMT may soon This same gene leads to judged to be unforeseeable by replace the blood test. Approxi- appropriate metabolism of pharmacists, regulators have mately 10 percent of people fluoxitine, and an inactive not criticized pharmacists have inherited a bad copy of form of the gene may cause whose patients suffered from the TPMT gene, which makes toxic overaccumulation of that these effects. them sluggish metabolizers of drug, leading to hypertension and other preventable side Pharmacists have, with frustra- 6-mercaptopurine and necessi- effects. With the advent of tion, long observed the “idio- tates a reduction in dose. A pharmacogenomics, these syncratic” effects of drugs that small percentage of people have adverse effects will no longer fail to help some patients and inherited two bad copies of the be considered idiosyncratic. actually harm others. At least gene, making them “exquisitely They will be known, predict- some of the problems with sensitive” to the drug and able, and preventable. “idiosyncrasies” (the word is requiring as much as a 95 derived from the Latin “idiota” percent reduction in dose. The advent of pharmaco- for “ignorant person” – not a Another example of how genomics will challenge phar- particularly flattering phrase, pharmacogenomics can be macy regulators to address new but one that correctly connotes applied to practice is based on issues regarding the a lack of knowledge rather than variation in the enzyme pharmacist’s standard of care a disregard for others) will soon cytochrome p4502d6 (2d6). This and public health protection. be addressed by advances in enzyme is necessary to metabo- At least four areas of pharmacy “pharmacogenomics.” The field lize many commonly used regulation will be profoundly of pharmacogenomics is based drugs. Learning whether a affected by pharmacogenomics: on the assumption that patient patient is a good or poor 2d6 (1) accuracy, (2) safety, variations in response to drugs (3) efficiency, and (4) quality. M A R C H 2 0 0 1 42 These are traditional areas of The safety mandate in phar- Generic substitution, thera- pharmacy regulation, but macy practice has been widely peutic interchange, and drug standard approaches to regula- publicized as of late, in part utilization evaluation are all tion within these four tradi- due to the report by the activities that require the tional areas may fail to reflect Institute of Medicine titled To application of patient care the quantum leap in practice Err is Human: Building a Safer expertise, with an eye toward that occurs when the applica- Health System. Pharmacists are stewardship of available tion of pharmacogenomics seen as a filter at the end of a resources. Pharmacists will becomes widespread. chain of drug distribution certainly be required to use

The accuracy mandate in events, having responsibility to pharmacogenomic expertise to pharmacy practice is widely ensure that decisions made prevent the use of therapies recognized and is firmly earlier in the chain were valid that are known to be ineffective established. Pharmacists have and predictive of success in based on a patient’s genetic a responsibility to get the right drug therapy. Through drug use makeup. This activity raises drug to the right patient at the review, pharmacists detect the specter of “therapeutic right time with the correct potential problems with drug discrimination” because directions for use. As simple as therapy, and they act to remove sometimes genetics are race- this mandate seems, the reality those problems to prevent harm based, and pharmacists may is that pharmacists do make to patients. Pharmacists detect have to deny a drug to a mistakes, and systems of prescriber errors, and they patient based on that patient’s pharmacy practice actually “set contact the prescriber to correct race. Pharmacy regulators must pharmacists up” to commit circumstances that pose an ensure that decisions about errors. One of the most basic unnecessary threat of harm to access to therapy are made reasons for error in order patients. Pharmacists also based on socially prescribed processing is that the opportu- promote patient safety by criteria and not on prejudicial nities for error are widespread. detecting and reporting adverse personal attitudes. There are more drugs now than drug reactions, so that product- The quality mandate derives in the past, the medication use related problems can be identi- primarily from the patient process is more complex than fied. Pharmacogenomics will counseling responsibilities and in the past, and complexity challenge pharmacists to ensure the collaborative practices produces error. that the drug variant prescribed between physicians and for a patient is the appropriate Pharmacogenomics will lead to pharmacists, which have one, given the patient’s genetic a more complex array of become recognized under board profile. Pharmacy regulators pharmaceuticals from which to of pharmacy acts and rules in a must enable pharmacists to choose. Abandonment of the majority of states. Pharmacists perform this expanded patient one-size-fits-all approach to will be required to educate safety activity. drug therapy will lead to an physicians and patients increased number of tailor- The efficiency mandate has regarding pharmacogenomics made drugs that present more created responsibilities for because it is a difficult field to opportunities to dispense the pharmacists to ensure not only understand, and there is the wrong drug. Pharmacy regula- that patients receive an possibility of an elevated tors will have to enable phar- appropriate drug but also that standard of care that will macists to develop better funds are not unnecessarily require provision to a patient systems to accommodate the expended on products and of the most appropriate drug increased opportunity for error. services that are of little value. for that specific individual (continued on page 49)

M A R C H 2 0 0 1 43 New Online Pharmacy Models Expand Practice Landscape (continued from page 39) revenue. For example, Miami, The Future of Internet drugstore.com sales almost Fla-based Clickpharmacy.com, Pharmacies doubled in the fourth quarter designed for independents, of 2000, from $18.5 million to The economic downturn in handles purchasing on its $36.2 million, according to dot.coms during the last year own site and sends orders via online news service eBiz. has had an impact on Internet e-mail to one of its 40 par- pharmacies, but the future Pharmacies are finding that by ticipating pharmacies in 38 remains bright for market forming partnerships they are states. It retains a commis- growth. Online prescription able to broaden services and sion for each purchase. drugs sales are expected to rise, keep abreast of an evolving, In addition to these four basic from $23 million in 2000 to competitive marketplace. service models, there are also $1 billion by 2002, according to Whatever the service model, other specialty or local online Internet business researcher the largest online pharmacies pharmacies whose operations Jupiter Communications. provide similar perks, such as fall outside the established Drugstore.com announced in phone and e-mail answering categories. These are generally January 2001 that it was services, health information, niche market pharmacies that cutting 125 jobs, or 23% of its e-mail prescription refill focus their efforts on a single staff, in addition to the 60 jobs reminders, and sometimes site- market, such as home therapy, it cut in October 2000 to sponsored support groups. HIV, or intravenous materials. reduce its operating costs. Yet With the continued growth of the Internet there is the need to ensure the protection of the NABP Awards VIPPS Certification public health through quality assurance and certification of to Eckerd.com online sites. When NABP created the Verified Internet Eckerd.com is the most recent e-commerce. “Our online Pharmacy Practice Sites™ online pharmacy to receive pharmacy customers can be (VIPPS™) program in January Verified Internet Pharmacy assured that the Eckerd Web 1999, it was expected that most Practice Sites™ (VIPPS™) site complies with the highest parties applying for certification certification from NABP. standards in the industry.” would be individual pharmacies Eckerd’s Web site is located at Participation in the VIPPS acting alone. However, medium www.eckerd.com. certification program is volun- and large organizations com- Eckerd Corporation, a wholly tary. The program was devel- pose the majority of applicants. owned subsidiary of Clearwater, oped to provide consumers with Other VIPPS-certified pharma- Fla-based JC Penney Co, is one a reliable means to identify cies not mentioned above are: of the United States’ largest those online pharmacies that accuratepharmacy.com, retail drug chains with 2,600 have proven their preparedness DrugEmporium.com, Health- drug stores in 20 states. Eckerd to meet the unique challenges Script Pharmacy Services, Inc, employs more than 78,000 of the practice of pharmacy via PrescriptionOnline.com, Tel- associates company-wide, the Internet. Drug, Inc, and VitaRx.com. including 9,000 pharmacists. For more information about In general, pharmacies have “Eckerd is dedicated to provid- the VIPPS program, call NABP found that they benefit from the ing the highest quality of at 847/698-6227, or log on to high level of Internet sophistica- service for our online pharmacy NABP’s Web site at tion available through networks customers,” says Mike Fidella, www.nabp.net. or other forms of partnerships Eckerd vice president of that they usually cannot provide themselves.

M A R C H 2 0 0 1 44 VIPPS Recommended by Consumer Reports, HHS, and Others

As more patients turn to the legitimate VIPPS sites, and can be accessed at Internet for medication suggests that patients look for www.medicare.gov/Prescrip- purchases, NABP’s Verified sites bearing the VIPPS seal. tion/Home.asp. Internet Pharmacy Practice The article explains that the Additional support for the Sites™ (VIPPS™) program is VIPPS seal is “designed to help VIPPS program comes from finding its way into the consumers identify sites that USA Today and Physician recommendations of maga- are licensed and in good stand- News, and the popular news zines, medical journals, and ing with regulatory agencies.” portal About.com, which online medical referral sites. Consumer Reports is the latest recommended the program in Consumer Reports magazine, consumer-oriented publication a recent legal column. in its February 2001 issue, to endorse NABP’s VIPPS MedWebPlus.com, one of the suggested to its 4.1 million program since it debuted in most relied-upon health subscribers that they look 1999. In January 2001, the US science information search for the VIPPS seal when Department of Health and sites on the Web, keeps purchasing prescription Human Services released a VIPPS on its approved drugs online. guide to Medicare patients database list, and the The article, “Prescription for regarding Internet pharmacy American Medical Associa- Trouble,” warns readers safety. The two-page bulletin tion pledged to cooperate against using online pharma- explained, “VIPPS certifies that with NABP on the program. cies that sell drugs without a the Internet pharmacy is fully VIPPS is also mentioned on prescription or those that licensed and complies with many other Internet health sell unsafe or counterfeit standards including protection information portals and drugs. It also refers to of your medical information.” It news services.

CybeRx-Smart Coalition Offers Tips for Online Rx Safety

Adhering to a few simple, information brochure that n Look for easy-to-find and common sense precautions, appears on the FDA Web site at understandable privacy and such as looking for the Verified www.fda.gov. security policies; and Internet Pharmacy Practice Through the efforts of the n Use the same standards SitesTM (VIPPSTM) seal, offers Coalition, FDA has made a when purchasing prescrip- consumers significant protec- significant commitment to tion medications online as tion when purchasing prescrip- educating consumers about the you would when selecting tion medicines online, says the “do’s and don’ts” of buying any reputable pharmacy. CybeRx-Smart Safety Coali- prescription medication online. Consumers are also encouraged tion. Organized by the US Food Consumers are advised to: to report any site they believe and Drug Administration (FDA) n to be unlicensed or a problem and comprised of 14 govern- Meet with their doctors to to the FDA. ment, professional, and indus- obtain any new prescription; try related organizations, n Look for the VIPPS seal to FDA’s future plans to widely including NABP, the Coalition ensure they are dealing with promote the Coalition brochure has launched a national public a legitimate pharmacy; include the distribution of a service campaign featuring card with every tax refund n Buy only from US-based sites; public service radio announce- check listing the new brochure, ments, news releases, and an (continued on page 49)

M A R C H 2 0 0 1 45 97th AnnualMeeting Optional Events, Spouse/Guest Program Enhance 97th Annual Meeting

Nestled on the coast of the it looked in 1889 before the States, and spouses and guests Pacific Ocean, Seattle is a Great Seattle Fire. Moving can explore glass blowing and playground for those who enjoy topside, the tour will continue the Pioneer Square Galleries the great outdoors. NABP has firsthand on a tour Tuesday, arranged an assortment of May 8. This optional tour will optional events for attendees visit art glass galleries located and their guests to explore in such diverse neighborhoods Seattle during the 97th Annual as Pioneer Square, Belltown, Meeting, May 5-9, 2001, at the and Eastlake. Participants will Sheraton Seattle Hotel and see glass blowing demonstra- Towers in Seattle, Wash. tions by prominent glass artists creating beautiful works of art. Optional Events There may even be a chance to NABP’s fourth annual golf purchase some of these works. tournament will be held at After the tour participants will Seattle Harbour Pointe, one have an opportunity to explore of Puget Sound’s most Pike Place Market, the histori- popular and challenging cal farmers’ market in down- This is just a sample of the many things courses. The first nine holes Seattle offers. From experiencing the town Seattle. There will be great outdoors to museums, there is wind around acres of wet- something for everyone. enough time to enjoy lunch in lands and lakes, while the the Market before heading forested back nine, with island- through Pioneer Square, back to the hotel. Cost of the like fairways, offer glimpses of Seattle’s oldest neighborhood, tour is $42. Advance registra- Puget Sound and Whidbey and home to many of the city’s tion is required. Island. Buses for the tourna- galleries and eateries. Visitors ment will leave the Sheraton at will have time to stroll through

1:30 PM on Monday, May 7, with stores offering everything from a “shotgun” start scheduled for valuable antiques and hand-

2 PM. The cost is $150, including made toys to books. The tour greens fee, cart rental, and ends with dinner at the re- prizes. Interested golfers are nowned Pyramid Ale House. encouraged to complete the The cost of the tour, including appropriate section of the dinner, is $61 per person. registration form and mail it to Jump start your day on the NABP office along with the Tuesday, May 7, with an activity fee by April 20, 2001. exhilarating run or a guided Historic cobblestone streets lead to Seattle’s Pike Place Market, one of the Meeting attendees and their walk through scenic Seattle. last remaining working farmers’ markets in the country. guests won’t want to miss the Guides will be sensitive to Sunday, May 6, optional the fitness level and desired walking tour of Underground intensity of their group. The Spouse/Guest Events Seattle and Pioneer Square, walking guide will narrate the NABP has arranged several which will be followed by walk, pointing out interesting programs for spouses and dinner at the Pyramid Ale sights, architecture, and guests of meeting attendees. House. Beginning beneath the public art highlights. On Sunday, May 6, spouses sidewalks of Pioneer Square, Seattle has become the art and guests will glimpse the visitors will glimpse the city as glass capital of the United (continued on page 51)

M A R C H 2 0 0 1 46 97th Annual MeetingProgram May 5-9, 2001 Sheraton Seattle Hotel and Towers Seattle, Wash

Friday, May 4 1:30 - 3 PM 12:30 - 3:30 PM 3 - 5 PM Spouse/Guest Tea Meeting of the Committee Registration Desk Open Microsoft Home of the Future on Resolutions 1:30 - 7 PM Saturday, May 5 2:30 - 4:30 PM Executive Officer Golf Tournament 7 AM - 7:30 PM and Board Member Registration Desk Open Programming Tuesday, May 8 Electronic Prescribing and 6:30 -7:30 AM 7:30 AM - 5:30 PM Electronic Signatures Fun Run/Walk Pre-Meeting Seminar Program #: 205-000-01-001-L03 Pharmacy-Based Immunization (0.2 CEUs – 2.0 contact hours) 8 AM - 5 PM Delivery: A Certificate Program Compliance Officer Registration Desk Open for Pharmacists Programming 8 - 9 AM Presented by the American Assessing the Pharmacy Work- Pharmaceutical Association place – Nevada Survey Results Past Presidents’ Breakfast Program #: 202-000-00-105-L01 Program #: 205-000-01-002-L03 8 - 9 AM (1.8 CEUs – 18 contact hours including (0.2 CEUs – 2.0 contact hours) home study module) Continental Breakfast Pharmacy Practice Programming 1 - 3 PM 9 - 11 AM Opioids and the Law Public Board Member Session Program #: 205-999-01-003-L03 Joint CE Programming (Subject to advance registration of at (0.2 CEUs – 2.0 contact hours) Socratic Dialogue: Regulating least 10 public members.) for Pharmaceutical Care Outcomes PM 1 - 5 PM 5:30 - 10:30 Program #: 205-000-01-007-L03 Presentation Area Open Optional Tour (0.2 CEUs – 2.0 contact hours) Underground Seattle PM 9 AM - 1:30 PM 1 - 5 and Pioneer Square Hospitality Suite Optional Spouse/ Sponsored by the Food Monday, May 7 Guest Tour Marketing Institute Glass Blowing and 7 - 11:30 AM 3 - 5 PM Pike Place Market Tour Registration Desk Open New Member Seminar 11 AM - noon 4 - 5 PM 7 - 8 AM Open Mike Session Meeting of the Nominating NABP/USP Breakfast 1 - 2:30 PM Committee Sponsored by the US Pharmacopeia, Inc Executive Officer 7 - 9 PM 8 - 9:30 AM and Board Member President’s Welcoming Executive Officer Programming Reception and Board Member HRSA Report on Pharmacy Programming Manpower Shortage Sunday, May 6 Program #: 205-000-01-008-L04 Legislative and (0.15 CEUs – 1.5 contact hours) 7:30 AM - 4:30 PM Regulatory Update Compliance Officer Registration Desk Open Program #: 205-000-01-004-L03 (0.15 CEUs – 1.5 contact hours) Programming 7:30 - 8:30 AM Pharmaceutical Care Outcomes: Compliance Officer Continental Breakfast The Compliance Perspective Programming Program #: 205-000-01-009-L03 7:30 AM - 2 PM Electronic Prescribing (0.15 CEUs – 1.5 contact hours) Presentation Area Open and Electronic Signatures Pharmacy Practice Programming Program #: 205-000-01-005-L03 8:30 - 8:45 AM Hooked on a Feeling: Where Have (0.15 CEUs – 1.5 contact hours) Welcoming Remarks/ We Gone Wrong in Managing Pain? Presentation of Colors Pharmacy Practice Programming Program #: 205-999-01-010-L01 What’s So Bad About Feeling (0.15 CEUs – 1.5 contact hours) 8:45 - 9:30 AM Good? The Ethics of Pain Keynote Address Management 3 - 4:30 PM Dr Robert D. Ballard, oceanographer Program #: 205-999-01-006-L04 Third Business Session (0.15 CEUs – 1.5 contact hours) 10 AM - 12:30 PM 7 - 10:30 PM First Business Session 9 - 11 AM Annual Awards Dinner Spouse/Guest Workshop 12:30 - 5 PM Feng Shui Demonstration Wednesday, May 9 Meeting of the Nominating Committee 9:45 AM - noon 7:30 - 8 AM Meeting of the Committee Second Business Session/ Continental Breakfast on Resolutions Committee and Task Force 8 - 11:30 AM Reports Final Business Session

NABP and the NABP Foundation are approved by the Participants may earn up to seven hours of ACPE-approved continuing education American Council on Pharmaceutical Education credit from NABP. Participants in continuing pharmaceutical education programs (ACPE) as providers of continuing pharmaceutical will receive credit by completing a “Certificate of Continuing Pharmaceutical education. ACPE Provider Number: 205 Education Participation,” and submitting it to the NABP office. A validated The American Pharmaceutical Association is approved Certificate will be sent as proof of participation within approximately six weeks. by the ACPE as a provider of continuing Full attendance and completion of a program evaluation form for each session are pharmaceutical education. ACPE Provider required to receive continuing pharmaceutical education credit and a Certificate Number: 202. of Participation.

M A R C H 2 0 0 1 47 HRSA Releases Results of Pharmacist Manpower Study (continued from page 38)

The Supply of number of pharmacists per least two semesters of super- Pharmacists and 100,000 population varied from vised practice experience. As a Pharmacy Education a low of 39 in Alaska to a high result, the number of pharmacy and Training of 103 in Nebraska. The graduates has been fewer nationwide average was 68 during this conversion process The overall number of active (pharmacists per 100,000 due to the extra year required to pharmacists is expected to population), up from 65 in complete the PharmD program. grow by 28,500 in the next 10 1978. Among states with the years, from 196,000 in 2000 to largest populations, California, Summary of Comments 224,500 in 2010. This is with only 54 pharmacists (per from Public and slightly less than the total 100,000 population), was well Private Sectors growth during the past decade below the national average.” (29,300). There has also been a Comments to the study group Another factor in the pharma- decline in pharmacy school largely supported HRSA’s cist shortage equation is applications, with the number findings that there is a true, pharmacy education and of 1999 applicants 33% lower long-term shortage of pharma- training. Although the number than in 1994, the high point of cists affecting the practice of of pharmacists has grown over the past decade. The composi- pharmacy and the public the past 20 years, the growth tion of practicing pharmacists health, not a short-term pattern for new graduates has is changing, too. Continuing problem resulting from market been somewhat irregular. A the pattern of the last decade, competition. The pharmacist decline in the number of the report projects that by 2010 shortage has had crucial pharmacy graduates in the late the number of women in the consequences affecting the 1990s was accompanied by a profession will increase, procurement of pharmaceutical corresponding decline in the outnumbering their male services and the practice of number of applications to counterparts by almost two to pharmacy including: schools of pharmacy. Two one. The number of women in n Limited services in some factors that influenced the the profession increased from pharmacies due to the decline in graduates were the 12.5% in 1970 to 46.1% in inability to fill vacant economic recession during the 2000. While this increase has positions and fulfill staffing; 1980s and the conversion from positive aspects in terms of n the bachelor of science in Job stress, poor work gender equality, this shift has pharmacy (BS Pharmacy) to conditions, and reduced had an impact on productivity doctor of pharmacy (PharmD) job satisfaction due to because many women opt to as the entry-level degree for longer working hours and work a part-time schedule. The pharmacists. Although cur- less flexibility in Bureau of Census’ Current rently the BS Pharmacy scheduling work; Population Survey reported programs are eligible for n The possibility for increased that between 1979 and 1998, accreditation by the American risk of medication errors 28% of the women worked less Council on Pharmaceutical due to pharmacist fatigue than 35 hours a week, as Education (ACPE) and meet and inadequate time for opposed to 11% of the men; the state boards of pharmacy patient counseling and/or almost 10% of the women licensure requirements, they error checking; worked less than 20 hours a are slowly being phased out. week as opposed to four n Increased burden of popula- After 2003 the ACPE will only percent of the men. tions and communities that accredit PharmD programs. The are medically underserved or The Census report also showed PharmD program requires at otherwise at risk; and that the “pharmacist supply least eight semesters of profes- n Critical vacancies among varies considerably from state sional-level work, usually over faculty in pharmacy schools. to state. In 1991, during the a four-year period, including at last nationwide census, the M A R C H 2 0 0 1 48 The HRSA report does not useful first steps toward tions have assessed the phar- attempt to offer solutions to relieving the shortage, neither macist shortage and presented the pharmacist shortage. was judged to be a comprehen- their perspectives. Several individuals and groups sive, long-term solution. It was The HRSA report is available commenting on the report did, stressed by some respondents on the Web at www.bhpr.gov./ however, discuss the value of to the HRSA report that healthworkforce/ some remedies. Although the technicians must have effective pharmacist.html. For informa- use of technicians and the and suitable training. tion about NABP, visit application of automation and Within the last 18 months, www.nabp.net. technology were viewed as several professional associa-

CybeRx-Smart Coalition Offers Tips for Online Rx Safety (continued from page 45) radio public service announce- cal Association, American Association, National Council ments (an audience of over five Society of Consultant Pharma- on Patient Information and million has been reached to cists, American Society of Education, National Patient date); a banner page on the FDA Health-System Pharmacists, Safety Foundation, Web site; and an exhibit booth CornerDrugstore.com, PlanetRx.com, and the FDA. at several professional meetings CVS.com, drugstore.com, The Coalition brochure is during 2001. Federal Trade Commission, posted at www.fda.gov/cder/ Member organizations of the NABP, National Association of drug/consumer/buyonline/ CybeRx-Smart Safety Coalition Chain Drug Stores, National guide.htm. are the American Pharmaceuti- Community Pharmacists

The AcademicPerspective (continued from page 43) patient. The collaboration with Pharmacists will be prominently such as pharmacogenomics, can physicians and patients will involved with pharmacogenomic be applied productively to require not only expertise decisions, and they will, at patient care. Perhaps most regarding therapy, but also times, fail to meet their respon- importantly, pharmacy regula- expertise in values and ethics sibilities. The job of the regulators must educate themselves as well because some physi- tory agency is to define for about pharmacogenomics, so cians and patients will object pharmacists the profession’s that when the time comes – and to pharmacogenomics due to a expectations of them, so that it will be soon – they will be well perceived “unnatural” aspect. practitioners are not left to positioned to provide leadership Pharmacy regulators will have guess what they should do in to the profession regarding the to adjust their expectations of their practice. Regulators also role pharmacists must play in pharmacists to reflect the have the ability to empower the improvement of outcomes expanded responsibility of practitioners to avail themselves and reduction of costs from individualized drug therapy. of productive advances in care, drug therapy based on such as pharmacogenomics. It Every advance in therapy brings pharmacogenomics. is regulators who must ensure with it solutions to old prob- Attorney David Brushwood is a the competence of licensed lems, along with an array of professor at the University of practitioners by acting to new problems that require Florida College of Pharmacy. He provide opportunities for creative new solutions. holds degrees from the Univer- practitioners to learn how Pharmacogenomics is no sity of Kansas, Schools of quantum advances in therapy, exception to this general rule. Pharmacy and Law.

M A R C H 2 0 0 1 49 NABP’s Examination Committee Members

The review committees for NABP’s competence mittee, the Multistate Pharmacy Jurisprudence assessment programs are charged with safeguard- Examination (MPJE™) Review Committee, and ing the integrity and validity of the Association’s the Disease State Management (DSM) Examina- examinations. These committees meet regularly to tion Review Committee start their terms at the review examination content and ensure that the beginning of the year, while members of the specified Competency Statements are met. The Foreign Pharmacy Graduate Equivalency Exami- individuals listed below currently serve on NABP’s nation (FPGEE®) Review Committee begin their examination committees. terms in the summer.

Members of the North American Pharmacist Licensure Examination (NAPLEX®) Review Com-

DSM Examination Review Committee Member ...... Holly L. Mason Member ...... George Alexis Purdue University Marshfield, Mass Member ...... Ralph Raasch Member ...... Joseph M. Calomo University of North Carolina – Chapel Hill Gloucester, Mass Member ...... Timothy J. Smith Member ...... Tina W. Dancer University of the Pacific Madison, Miss Member ...... Sr Margaret Wright Member ...... Mark C. Granberry Arlington Heights, Ill University of Arkansas for Medical Sciences Member ...... Dale Eric Wurster, Jr Member ...... Jill T. Johnson University of Iowa University of Arkansas for Medical Sciences Member ...... David Zgarrick Member ...... JaCinda L. Jones Midwestern University St Louis, Mo MPJE Review Committee Member ...... W. Greg Leader Member ...... Rosalie Baran University of Louisiana at Monroe Michigan Board of Pharmacy Member ...... James W. Lewis Member ...... Cynthia Benning Wilmington, Del Wisconsin Pharmacy Examining Board Member ...... Robert P. Paone Member ...... J.D. Coffey Braintree, Mass Massachusetts Board of Registration in Pharmacy Member ...... James J. Pohlman Member ...... John A. Fiacco Rockford, Ill New York Board of Pharmacy Member ...... Eric F. Schneider Member ...... Denise Frank University of Arkansas for Medical Sciences Princeton, Minn Member ...... Susan Spivey-Miller Member ...... Michael A. Moné Gainesville, Fla Kentucky Board of Pharmacy Member ...... David Young Member ...... Jerry Montoya University of Utah New Mexico Board of Pharmacy FPGEE Review Committee Member ...... Richard Morrison Member ...... Louis N. Ace, Jr Washington State Board of Pharmacy University of Louisiana at Monroe Member ...... Steve Morse Member ...... Charles Barfknecht Texas State Board of Pharmacy University of Iowa Member ...... Charles W. Sauer Member ...... John H. Block Darien, Ill Oregon State University Member ...... Alan M. Shepley Member ...... Stephen L. Dahl Mount Vernon, Ill Kansas City, Mo Member ...... John D. Taylor Member ...... William R. Garnett Florida Board of Pharmacy Virginia Commonwealth University Ex-Officio Member ...... Denise Curry Member ...... J. Keith Guillory US Drug Enforcement Administration University of Iowa Ex-Officio Member ...... Thomas J. McGinnis Member ...... Boka Hadzija US Food and Drug Administration University of North Carolina – Chapel Hill Member ...... Monina Lahoz Massachusetts College of Pharmacy and Health Sciences

M A R C H 2 0 0 1 50 NABP’s Examination Committee Members NAPLEX Review Committee Member ...... Susan C. Lutz Member ...... Loyd V. Allen, Jr Altoona, Iowa Edmond, Okla Member ...... Gene Martin Member ...... Dyke F. Anderson Pensacola, Fla Nebraska Board of Pharmacy Member ...... Warren A. Narducci Member ...... Christi Capers University of Washington Mercer University School of Pharmacy, Ga Member ...... David W. Newton Member ...... Thomas S. Foster Shenandoah University, Va Lexington, Ky Member ...... Stephen M. Ouellette Member ...... Darla Gallo Oakland, Me Elkins, Pa Member ...... Roy C. Parish Member ...... W. Franklin Gilmore University of Louisiana at Monroe Montana Tech of the University of Montana Member ...... W. Steven Pray Member ...... Edward A. Hartshorn Southwestern Oklahoma State University Houston, Tex Member ...... David B. Roll Member ...... Robert P. Henderson University of Utah Samford University, Ala Member ...... Pamela P. Rush Member ...... William A. Hopkins, Jr University of Missouri Big Canoe, Ga Member ...... Eric F. Schneider Member ...... Tom M. Houchens University of Arkansas for Medical Sciences London, Ky Member ...... James A. Seaboldt Member ...... Arthur I. Jacknowitz Denver, Colo West Virginia University Member ...... John L. Szarek Member ...... Dennis D. Killion Marshall University, WVa Red Oak, Iowa Member ...... Neal F. Walker Member ...... Jeff Lurey University Medical Center – Mesabi, Minn Georgia State Board of Pharmacy

Association Committee and Task Force Volunteers Needed

NABP is seeking volunteers Secretary Carmen A. Catizone All letters and vitae will be from among its active member by Thursday, May 31, 2001. forwarded to NABP President- boards of pharmacy to serve on Letters should outline the elect Richard K. “Mick” the Association’s 2001-2002 volunteer’s applicable experi- Markuson, who will make the committees and task forces. ences and accomplishments, appointments following the th Interested executive officers and along with the reasons he or Association’s 97 Annual board members are encouraged she wishes to be considered for Meeting, May 5-9, 2001, in to submit a letter of interest appointment to a task force Seattle, Wash. and a current curriculum vitae or committee. to NABP Executive Director/

th Optional Events, Programs Enhance 97 Annual Meeting (continued from page 46) house of the future during a and at home. The future may of positive energy in an envi- presentation by Microsoft’s not be too far away after all. ronment. Participants will

Rick Bakken, who will explain Interested in restoring positive learn how to diagnose missing how computers will someday energy in your life? Plan to elements that disrupt the flow work with wireless networks attend the Feng Shui Demon- of positive energy and adopt and intelligent devices and stration on Monday, May 7, to certain strategies to restore appliances to help the busy gain insight into this 5,000- harmony and balance to their st people of the 21 Century live a year-old Chinese philosophy surroundings. digital lifestyle both at work that seeks to enhance the flow

M A R C H 2 0 0 1 51 ComplianceNews Mississippi Board Pursues ment but stresses that the since in many cases it has been Diversion Problem Board has been aggressively the most trusted employee who pursuing the drug diversion has been diverting medication A pharmacy technician em- problem during the last year- for a long time. Stamps esti- ployed for more than four years and-a-half through articles in mates that in the case of more at a moderate-volume, major the Mississippi State Board of than half of the arrested chain pharmacy in Gulfport, Pharmacy Newsletter. technicians, there is strong Miss, allegedly diverted more reason to believe that they than 35,000 dosage units of Stamps recommends that have taken the job to have hydrocodone and alprazolam background checks be done on access to drugs. over a seven-month period. every prospective employee. He Another pharmacy technician in also suggests that different The drugs may be given to a similar size chain in Long persons order and check in drug friends, sold on the street, or Beach, Miss, allegedly inflated shipments and that someone taken for personal use. Street her drug orders for medications look over the purchase process. prices for hydrocodone tablets such as Lorcet 10 and Vicodin Problems arise, he notes, when range from $6 to $10 per tablet, ES over a period of five months. the same person is allowed to while prices for alprazolam The diversions were detected place and check the order range from $2 to $4 per tablet. internally by staff pharmacists without requiring anyone else to In one case, Lorcet 10 and who looked at records of verify it. Sometimes invoices Vicodin ES tablets were sold for delivered drugs. Both techni- have been replaced to show $3 each to an out-of-state cians were arrested. lower amounts delivered. person, who then sold the drugs for $10 per unit. Drug diversion occurs through- “We’re getting better at detec- out the country, and state tion and education,” notes The Mississippi Board has boards that are focusing efforts Stamps. “PICs are doing a better conducted about 20 such at educating pharmacies are job watching and handling investigations since fall 1999, curtailing abuses. In both cases routine invoices, watching which account for 300,000 above, the diversions could have purchasing patterns, and dosage units of missing pre- been avoided if the pharmacist- maintaining normal, good scription drugs. Twenty-one in-charge (PIC) had simply business practices.” technicians have been arrested, reviewed the purchase invoices According to Stamps, pharma- and four more have voluntarily and kept a closer watch over the cists are making more reports to surrendered their registrations. drug purchase procedure, says the state Board. Constant Six investigations are presently Mississippi State Board of vigilance is important, he says, underway. Pharmacy Director of Compli- ance Harold J. Stamps.

“We’ve noticed a huge increase LegalBriefs (continued from page 41) of diversion involving pharmacy technicians,” Stamps says, physician under these circum- practice acts must be examined noting that the increase began stances. Boards of pharmacy in making such determinations. around April 1999, the same must be careful in adopting Miller v. Board of Medical time that a new state pharmacy policies relative to the investi- Examiners of the State of Iowa, regulation required pharmacy gative process and disclosure of 609 N.W.2d 478 (IA 2000) technicians to be registered with information. Several laws must the state Board. He says it is be examined to determine Attorney Dale J. Atkinson is a unclear why diversion increased whether such policies will partner in the law firm of simultaneously with the withstand legal scrutiny. Atkinson & Atkinson, counsel technician registration require- Obviously, more than the for NABP.

M A R C H 2 0 0 1 52 Roster of Board of PharmacyExecutives

ALABAMA ILLINOIS Jerry Moore, Executive Secretary Sandra Dunn, Pharmacy Coordinator 1 Perimeter Park South, Suite 425 South 320 W Washington, Third Floor, Birmingham, AL 35243 Springfield, IL 62786 205/967-0130, fax 205/970-6846 217/785-0800, fax 217/782-7645 [email protected] INDIANA ALASKA Mark Bina, Director Debora Stovern, Licensing Examiner 402 W Washington St, Room 041 PO Box 110806, Juneau, AK 99811 Indianapolis, IN 46204-2739 907/465-2589, fax 907/465-2974 317/232-1140 fax 317/233-4236 [email protected] ARIZONA L A Lloyd, Executive Director IOWA 4425 W. Olive Avenue, Suite 140 Lloyd K Jessen, Executive Secretary/Director Glendale, AZ 85302-3844 400 SW Eighth St, Suite E, 623/463-2727, fax 623/934-0583 Des Moines, IA 50309-4688 [email protected] 515/281-5944 fax 515/281-4609 [email protected] ARKANSAS Charles S Campbell, Executive Director KANSAS 101 E Capitol, Suite 218, Little Rock, AR 72201 Susan Linn, Executive Secretary 501/682-0190, fax 501/682-0195 Landon State Office Bldg, [email protected] 900 Jackson, Room 513 Topeka, KS 66612 CALIFORNIA 785/296-4056 fax 785/296-8420 Patricia F Harris, Executive Officer [email protected] 400 R St, Suite 4070, Sacramento, CA 95814 916/445-5014, fax 916/327-6308, KENTUCKY [email protected] Michael A Moné, Executive Director 23 Millcreek Park, Frankfort, KY 40601-9230 COLORADO 502/573-1580, fax 502/573-1582 Susan L Warren, Program Administrator 1560 Broadway, Suite 1310, LOUISIANA Denver, CO 80202-5146 Malcolm J Broussard, Executive Director 303/894-7750, fax 303/894-7764 5615 Corporate Blvd, Suite 8E, Baton Rouge, LA 70808 CONNECTICUT 225/925-6496 fax 225/925-6499 Michelle B Sylvestre, Board Administrator [email protected] 165 Capitol Ave, State Office Building, Room 147 Hartford, CT 06106 MAINE 860/713-6070, fax 860/713-7242 Geraldine “Jeri” L Betts, Board Administrator [email protected] Dept of Prof/Financial Reg, 35 State House Station, Augusta, ME 04333 DELAWARE 207/624-8603 fax 207/624-8637 David W Dryden, Executive Secretary [email protected] PO Box 637, Dover, DE 19903 302/739-4798, fax 302/739-3071, MARYLAND [email protected] Laverne George Naesea, Executive Director 4201 Patterson Ave, Baltimore, MD 21215-2299 DISTRICT OF COLUMBIA 410/764-4755 fax 410/358-6207 Graphelia Ramseur, Contact Representative [email protected] 825 N Capitol NE, Room 2224, Washington, DC 20002 MASSACHUSETTS 202/442-9200, fax 202/442-9431 Charles R Young, Executive Director 239 Causeway St, 5th Floor, Boston, MA 02114 FLORIDA 617/727-9953 fax 617/727-2366 John D Taylor, Executive Director [email protected] 4052 Bald Cypress Way, Bin #C04 Tallahassee, FL 32399-3254 MICHIGAN 850/414-2969, fax 850/413-6982 Cathy Seyka, Licensing Manager 611 W Ottawa, First Floor, PO Box 30670 GEORGIA Lansing, MI 48909-8170 Anita O Martin, Executive Director 517/373-9102 fax: 517/373-2179 237 Coliseum Dr, Macon, GA 31217-3858 www.cis.state.mi.us 478/207-1686, fax 478/207-1699 MINNESOTA GUAM David E Holmstrom, Executive Director Teresita Villagomez, Acting Administrator 2829 University Avenue SE, Suite 530 PO Box 2816, Hagatna, GU 96932 Minneapolis, MN 55414-3251 671/475-0251, fax 671/477-4733, 612/617-2201 fax 612/617-2212 [email protected] [email protected] HAWAII MISSISSIPPI Lee Ann Teshima, Executive Officer William L “Buck” Stevens, Executive Director PO Box 3469, Honolulu, HI 96801 PO Box 24507, Jackson, MS 39225-4507 808/586-2694, fax: 808/586-2689 601/354-6750, fax 601/354-6071 LeeAnn_N_Teshima/[email protected] [email protected] IDAHO MISSOURI Richard “Mick” Markuson, Executive Director Kevin E Kinkade, Executive Director 3380 Americana Terrace, Suite 320, PO Box 625, Jefferson City, MO 65102 Boise, ID 83706 573/751-0091, fax 573/526-3464 208/334-2356, fax 208/334-3536 [email protected] [email protected] M A R C H 2 0 0 1 53 MONTANA PUERTO RICO Rebecca Deschamps, Executive Director Beverly Davila Morales, Executive Director PO Box 200513, 301 S. Park Ave, 4th Floor Department of Health, Board of Pharmacy Helena, MT 59620-0513 800 Avenida Robert T. Todd, Office #201 406/841-2356 fax 406/841.2343 Stop 18 Santurce, PR 00908 [email protected] 787/725-8161 fax 787/725-7903 NEBRASKA RHODE ISLAND Becky Wisell, Executive Secretary Catherine Cordy, Acting Chief of the Board PO Box 94986, Lincoln, NE 68509-4986 3 Capitol Hill, Room 205, 402/471-2118, fax 402/471-3577 Providence, RI 02908-5097 [email protected] 401/222-2837 fax 401/222-2158 NEVADA SOUTH CAROLINA Keith W Macdonald, Executive Secretary Administrator 555 Double Eagle Court, Suite 1100, PO Box 11927, Columbia, SC 29211-1927 Reno, NV 89511 803/896-4700 fax 803/896-4596 775/850-1440 fax 775/850-1444 www.llr.sc.edu/bop.htm [email protected] SOUTH DAKOTA NEW HAMPSHIRE Dennis M Jones, Executive Secretary 4305 S Louise Ave, Suite 104, Paul G Boisseau, Executive Secretary Sioux Falls, SD 57106 57 Regional Dr, Concord, NH 03301-8515 605/362-2737 fax 605/362-2738 603/271-2350, fax 603/271-2856 www.state.sd.us/dcr/pharmacy [email protected] TENNESSEE NEW JERSEY Kendall M Lynch, Director Lois D. Johnson, Executive Director 500 James Robertson Pkwy, Second Floor H. Lee Gladstein, Director of Pharmacy Davy Crockett Tower, Nashville, TN 37243-1149 PO Box 45013, Newark, NJ 07101 615/741-2718, fax 615/741-2722 973/504-6450, fax 973/648-3355 [email protected] [email protected] TEXAS NEW MEXICO Gay Dodson, Executive Director/Secretary Jerry Montoya, Executive Director 333 Guadalupe, Tower 3, Suite 600, Box 21 University Towers, Suite 400B Austin, TX 78701-3942 1650 University Blvd NE, 512/305-8000, fax 512/305-8075 Albuquerque, NM 87102 [email protected] 505/841-9102 fax 505/841-9113 [email protected] UTAH Daniel T Jones, Bureau Manager NEW YORK PO Box 146741, Salt Lake City, UT 84114-6741 Lawrence H Mokhiber, Executive Secretary 801/530-6767, fax 801/530-6511 89 Washington Avenue, 2nd Floor West [email protected] Albany, NY 12234-1000 VERMONT 518/474-3817, fax 518/473-6995 Carla Preston, Staff Secretary [email protected] Office of Professional Regulation NORTH CAROLINA 26 Terrace St, Drawer 9 David R Work, Executive Director Montpelier, VT 05609-1106 PO Box 459, Carrboro, NC 27510-0459 802/828-2875, fax 802/828-2465 919/942-4454, fax 919/967-5757 [email protected] [email protected] VIRGIN ISLANDS NORTH DAKOTA Lydia T Scott, Executive Assistant Howard C Anderson, Jr, Executive Director Dept of Health, Roy L Schneider Hospital PO Box 1354, Bismarck, ND 58502-1354 48 Sugar Estate, St Thomas, VI 00802 701/328-9535, fax 701/258-9312 340/774-0117 x. 5078, fax 340/777-4001 [email protected] VIRGINIA OHIO Elizabeth Scott Russell, Executive Director William T Winsley, Executive Director 6606 W Broad St, Suite 400, 77 S High St, Room 1702 Richmond, VA 23230-1717 Columbus, OH 43215-6126 804/662-9911, fax 804/662-9313 614/466-4143, fax 614/752-4836 [email protected] [email protected] WASHINGTON OKLAHOMA Donald H Williams, Executive Director PO Box 47863, Olympia, WA 98504-7863 Bryan H Potter, Executive Director 360/236-4825, fax 360/586-4359 4545 Lincoln Blvd, Suite 112, [email protected] Ok. City, OK 73105-3488 405/521-3815, fax 405/521-3758 WEST VIRGINIA [email protected] William T Douglass, Jr, Executive Director OREGON 232 Capitol St, Charleston, WV 25301 Gary A Schnabel, Executive Director 304/558-0558, fax 304/558-0572 State Office Bldg, Room 425, WISCONSIN 800 NE Oregon St. #9 Patrick D Braatz, Executive Director Portland, OR 97232 1400 E Washington, PO Box 8935, 503/731-4032, fax 503/731-4067 Madison, WI 53708 [email protected] 608/266-2717, fax 608/267-0644 PENNSYLVANIA [email protected] Melanie A. Zimmerman, Executive Secretary WYOMING 124 Pine St, PO Box 2649 James T Carder, Executive Director Harrisburg, PA 17105-2649 1720 S Poplar St, Suite 4, Casper, WY 82601 717/783-7156, fax 717/787-7769 307/234-0294, fax 307/234-7226 [email protected] [email protected]

M A R C H 2 0 0 1 54 Around theAssociation In Memoriam: macy Law and the 1988 his 25-year tenure as a Sidney H. Willig President’s Medal from St Board member, “Harold John’s University. never missed an annual Sidney H. Willig, a pharma- meeting or a district meet- cist and attorney who was Johnson, Gladstein ing. He has always dedi- recognized as a leading cated the most amount of scholar in pharmaceutical New Roles time possible to the Board.” law and who served as in New Jersey counsel to some of the Lois D. Johnson has been In September 2000, Sparr, nation’s largest drug makers, appointed the new executive chairman of NABP’s Advi- died suddenly on November director of the New Jersey sory Council on Examina- 19, 2000. He was 81. Willig State Board of Pharmacy. tions, was awarded the served as professor, lecturer, Johnson holds a BS in President’s Pharmacist of and head of the drug law elementary education from the Year Award by the institute at Temple Univer- Fairleigh Dickinson Univer- Massachusetts Pharmacy sity in Philadelphia, Pa, sity. Prior to joining the Association. where a chair in pharmaceu- Board, she was the executive tical law was established in director of the New Jersey New Board Members his name. marriage and family therapy Following are newly ap- department for two years. pointed state board of He authored several books on H. Lee Gladstein is now the nursing, pharmacy, and drug pharmacy members. director of pharmacy for the law and was considered an Thomas A. Dickson, New Jersey State Board expert on product liability member, Minnesota Board of Pharmacy. as it relates to pharmaceu- of Pharmacy tical law. Harold Sparr Re-elected Lynda C. Staggs, member, “He took his knowledge as a Sixth Consecutive Term Alabama State Board pharmacist and used it with of Pharmacy Massachusetts Board of his knowledge of the law, so Registration in Pharmacy Malcolm “Mickey” Tatum, he became an expert on member Harold B. Sparr was Jr, member, Georgia State things like labeling and re-elected to a sixth consecu- Board of Pharmacy certification,” said his son, tive year as Board president. Richard P. Zarek, member, Kenneth Willig. Massachusetts Board Execu- Nebraska Board of Mr Willig received the tive Director Charles R. Young Pharmacy President’s Award of the praised Sparr’s contributions American Society for Phar- to the Board and noted that in

M A R C H 2 0 0 1 55 NABP Meeting Dates

Friday, March 30, 2001 Thursday-Saturday, August 16-18, 2001 Committee on Constitution and Bylaws Meeting, NABP/AACP District V Meeting, NABP Headquarters, Park Ridge, Ill Rushmore Plaza, Rapid City, SD Friday-Saturday, May 4-5, 2001 Thursday-Sunday, October 4-7, 2001 Pre-convention Executive Committee Meeting, NABP/AACP District VI Meeting, The Sheraton Seattle Hotel and Towers, TBA, Lawrence, Kan Seattle, Wash Thursday-Sunday, October 11-14, 2001 Saturday-Wednesday, May 5-9, 2001 NABP/AACP District VII & VIII Meeting, NABP 97th Annual Meeting, Sheraton Old Town Hotel, Albuquerque, NM The Sheraton Seattle Hotel and Towers, Thursday-Saturday, Seattle, Wash November 1-3, 2001 Wednesday, May 9, 2001 NABP/AACP District I & II Meeting, Post-convention Executive Committee Meeting Otesaga Hotel & Resort, The Sheraton Seattle Hotel and Towers, Cooperstown, NY Seattle, Wash Friday-Sunday, Sunday-Tuesday, August 5-7, 2001 November 9-11, 2001 NABP/AACP District III Meeting, NABP/AACP District IV Amelia Island Plantation, Amelia Island, Fla Meeting, Concourse Hotel, Madison, Wis

ON OF B TI OA IA R C D O S S S O A F newsletter P

L H

A National Association of Boards of Pharmacy

N Y 700 Busse Highway

1904 ® Park Ridge, Illinois 60068